Rhoen should buy shares to return cash to investors - chairman
FRANKFURT Nov 18 (Reuters) - Germany's Rhoen-Klinikum should buy up its own shares and cancel them to return cash to shareholders from the sale of hospitals to rival Fresenius, Chairman and founder Eugen Muench told a German newspaper.
"Whoever wants to sell his shares could then expect an offer of around 28 euros per share, that would be an attractive price," Sueddeutsche Zeitung quoted Muench as saying in an interview published on Monday.
Shares in Rhoen have advanced by 32 percent so far this year and ended Friday's session at 20.245 euros.
Muench in September hammered out a deal to sell hospitals accounting for about two thirds of Rhoen's revenues to healthcare group Fresenius for 3.07 billion euros ($4.14 billion).
He told Sueddeutsche Zeitung that minority shareholders would benefit more from a share buyback than a special dividend because they would have to pay less tax on the gain.
- Total CEO de Margerie killed in Moscow as jet hits snow plow |
- Sweden gets two new sightings, as hunt for undersea intruder goes on
- Pistorius starts five-year term for killing Reeva Steenkamp
- U.S. to funnel travelers from Ebola-hit region through five airports
- Ebola crisis turns a corner as U.S. issues new treatment protocols